Aclarion, Inc. (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company, announced it has received a Diamond Pinnacle Award for AI Innovation in the Clinical Decision AI category. The award recognizes the company’s use of artificial intelligence in its Nociscan solution, designed to help physicians locate the source of chronic low back pain. This recognition follows Aclarion’s earlier selection as a 2025 Digital Health Awards at HLTH winner, where Nociscan was honored for its potential to transform the evaluation and management of discogenic low back pain.
“Receiving recognition from both the Pinnacle Awards and HLTH underscores the accelerating momentum behind our technology. Chronic low back pain remains one of the most challenging and costly conditions in medicine,” said Brent Ness, CEO of Aclarion. The company’s Nociscan platform uses magnetic resonance spectroscopy (MRS) to identify chemical biomarkers within intervertebral discs. Proprietary augmented intelligence algorithms process these biomarkers to classify whether a disc’s biochemical profile is consistent with a painful or non-painful disc. Physicians use this objective data, combined with imaging and clinical evaluation, to optimize treatment planning.
Chronic low back pain affects approximately 266 million people worldwide, making it a significant global healthcare burden. Aclarion’s Nociscan is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. The platform is delivered through a cloud-based analytics system, enabling rapid deployment across imaging centers and health systems without requiring new hardware infrastructure.
“Providing physicians with objective biochemical data has the potential to fundamentally improve how discogenic pain is evaluated and treated,” Ness added. Clinical data demonstrates a 97% surgical success rate when all Nociscan-positive discs are treated, alongside other diagnostic tools.
The Pinnacle Awards recognize outstanding achievements in AI innovation across various industries. Aclarion’s win in the Clinical Decision AI category highlights the growing importance of AI in healthcare decision-making. The company continues to expand adoption of Nociscan among spine specialists seeking more objective tools for evaluating chronic low back pain.
For more information about Aclarion and Nociscan, visit www.aclarion.com. To find a Nociscan center, view the site map here.
